Logo image of PGRE

PARAMOUNT GROUP INC (PGRE) Stock Fundamental Analysis

NYSE:PGRE - New York Stock Exchange, Inc. - US69924R1086 - REIT - Currency: USD

6.12  +0.09 (+1.49%)

After market: 6.12 0 (0%)

Fundamental Rating

3

Overall PGRE gets a fundamental rating of 3 out of 10. We evaluated PGRE against 130 industry peers in the Diversified REITs industry. While PGRE seems to be doing ok healthwise, there are quite some concerns on its profitability. PGRE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PGRE had negative earnings in the past year.
PGRE had a positive operating cash flow in the past year.
PGRE had negative earnings in each of the past 5 years.
In the past 5 years PGRE always reported a positive cash flow from operatings.
PGRE Yearly Net Income VS EBIT VS OCF VS FCFPGRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of PGRE (-0.83%) is worse than 66.15% of its industry peers.
PGRE has a Return On Equity of -2.14%. This is in the lower half of the industry: PGRE underperforms 63.85% of its industry peers.
PGRE's Return On Invested Capital of 1.43% is on the low side compared to the rest of the industry. PGRE is outperformed by 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PGRE is in line with the industry average of 3.17%.
Industry RankSector Rank
ROA -0.83%
ROE -2.14%
ROIC 1.43%
ROA(3y)-1.42%
ROA(5y)-0.96%
ROE(3y)-3.53%
ROE(5y)-2.37%
ROIC(3y)1.5%
ROIC(5y)1.5%
PGRE Yearly ROA, ROE, ROICPGRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6 -8

1.3 Margins

PGRE has a Operating Margin of 18.73%. This is comparable to the rest of the industry: PGRE outperforms 41.54% of its industry peers.
In the last couple of years the Operating Margin of PGRE has declined.
PGRE has a Gross Margin of 59.03%. This is in the lower half of the industry: PGRE underperforms 70.00% of its industry peers.
PGRE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.73%
PM (TTM) N/A
GM 59.03%
OM growth 3Y-5.7%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5Y-1.42%
PGRE Yearly Profit, Operating, Gross MarginsPGRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

PGRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PGRE has about the same amount of shares outstanding.
PGRE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for PGRE has been reduced compared to a year ago.
PGRE Yearly Shares OutstandingPGRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
PGRE Yearly Total Debt VS Total AssetsPGRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

PGRE has an Altman-Z score of 0.19. This is a bad value and indicates that PGRE is not financially healthy and even has some risk of bankruptcy.
PGRE has a worse Altman-Z score (0.19) than 66.92% of its industry peers.
PGRE has a debt to FCF ratio of 43.45. This is a negative value and a sign of low solvency as PGRE would need 43.45 years to pay back of all of its debts.
PGRE's Debt to FCF ratio of 43.45 is fine compared to the rest of the industry. PGRE outperforms 65.38% of its industry peers.
A Debt/Equity ratio of 1.19 is on the high side and indicates that PGRE has dependencies on debt financing.
The Debt to Equity ratio of PGRE (1.19) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 43.45
Altman-Z 0.19
ROIC/WACC0.21
WACC6.72%
PGRE Yearly LT Debt VS Equity VS FCFPGRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

PGRE has a Current Ratio of 3.92. This indicates that PGRE is financially healthy and has no problem in meeting its short term obligations.
PGRE's Current ratio of 3.92 is amongst the best of the industry. PGRE outperforms 91.54% of its industry peers.
PGRE has a Quick Ratio of 3.92. This indicates that PGRE is financially healthy and has no problem in meeting its short term obligations.
PGRE's Quick ratio of 3.92 is amongst the best of the industry. PGRE outperforms 91.54% of its industry peers.
Industry RankSector Rank
Current Ratio 3.92
Quick Ratio 3.92
PGRE Yearly Current Assets VS Current LiabilitesPGRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1

3. Growth

3.1 Past

PGRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.27%, which is quite impressive.
PGRE shows a small growth in Revenue. In the last year, the Revenue has grown by 1.97%.
The Revenue has been growing slightly by 0.36% on average over the past years.
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)1.97%
Revenue growth 3Y1.39%
Revenue growth 5Y0.36%
Sales Q2Q%-5.53%

3.2 Future

Based on estimates for the next years, PGRE will show a very negative growth in Earnings Per Share. The EPS will decrease by -30.73% on average per year.
PGRE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.52% yearly.
EPS Next Y-11.71%
EPS Next 2Y-44.52%
EPS Next 3Y-30.73%
EPS Next 5YN/A
Revenue Next Year-5.69%
Revenue Next 2Y-4.74%
Revenue Next 3Y-3.52%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PGRE Yearly Revenue VS EstimatesPGRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
PGRE Yearly EPS VS EstimatesPGRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PGRE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PGRE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PGRE Price Earnings VS Forward Price EarningsPGRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

66.92% of the companies in the same industry are more expensive than PGRE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PGRE is valued cheaply inside the industry as 83.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.85
EV/EBITDA 12.13
PGRE Per share dataPGRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PGRE's earnings are expected to decrease with -30.73% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.52%
EPS Next 3Y-30.73%

0

5. Dividend

5.1 Amount

No dividends for PGRE!.
Industry RankSector Rank
Dividend Yield N/A

PARAMOUNT GROUP INC

NYSE:PGRE (7/31/2025, 8:04:00 PM)

After market: 6.12 0 (0%)

6.12

+0.09 (+1.49%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners73.54%
Inst Owner Change-0.41%
Ins Owners15.7%
Ins Owner Change0.39%
Market Cap1.34B
Analysts50.91
Price Target5.55 (-9.31%)
Short Float %4.29%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)-23.74%
DP-25.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-243.14%
Min EPS beat(2)-341.18%
Max EPS beat(2)-145.1%
EPS beat(4)1
Avg EPS beat(4)-123.86%
Min EPS beat(4)-341.18%
Max EPS beat(4)21.57%
EPS beat(8)4
Avg EPS beat(8)-309.98%
EPS beat(12)6
Avg EPS beat(12)-250.12%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-2.29%
Max Revenue beat(2)1.47%
Revenue beat(4)3
Avg Revenue beat(4)1.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)6.69%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)8
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.09%
PT rev (1m)4.82%
PT rev (3m)22.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.82%
Revenue NQ rev (3m)-1.74%
Revenue NY rev (1m)-1.3%
Revenue NY rev (3m)0.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.78
P/FCF 15.85
P/OCF 6.58
P/B 0.43
P/tB 0.44
EV/EBITDA 12.13
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)0.39
FCFY6.31%
OCF(TTM)0.93
OCFY15.2%
SpS3.45
BVpS14.08
TBVpS13.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.83%
ROE -2.14%
ROCE 1.81%
ROIC 1.43%
ROICexc 1.51%
ROICexgc 1.54%
OM 18.73%
PM (TTM) N/A
GM 59.03%
FCFM 11.2%
ROA(3y)-1.42%
ROA(5y)-0.96%
ROE(3y)-3.53%
ROE(5y)-2.37%
ROIC(3y)1.5%
ROIC(5y)1.5%
ROICexc(3y)1.58%
ROICexc(5y)1.58%
ROICexgc(3y)1.61%
ROICexgc(5y)1.61%
ROCE(3y)1.9%
ROCE(5y)1.89%
ROICexcg growth 3Y-2.68%
ROICexcg growth 5Y-0.82%
ROICexc growth 3Y-2.45%
ROICexc growth 5Y-0.45%
OM growth 3Y-5.7%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5Y-1.42%
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 43.45
Debt/EBITDA 9.71
Cap/Depr 50.25%
Cap/Sales 15.78%
Interest Coverage 250
Cash Conversion 53.82%
Profit Quality N/A
Current Ratio 3.92
Quick Ratio 3.92
Altman-Z 0.19
F-Score6
WACC6.72%
ROIC/WACC0.21
Cap/Depr(3y)48.92%
Cap/Depr(5y)46.58%
Cap/Sales(3y)15.71%
Cap/Sales(5y)15.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
EPS Next Y-11.71%
EPS Next 2Y-44.52%
EPS Next 3Y-30.73%
EPS Next 5YN/A
Revenue 1Y (TTM)1.97%
Revenue growth 3Y1.39%
Revenue growth 5Y0.36%
Sales Q2Q%-5.53%
Revenue Next Year-5.69%
Revenue Next 2Y-4.74%
Revenue Next 3Y-3.52%
Revenue Next 5YN/A
EBIT growth 1Y8.09%
EBIT growth 3Y-4.39%
EBIT growth 5Y-2.74%
EBIT Next Year140.11%
EBIT Next 3Y25.24%
EBIT Next 5YN/A
FCF growth 1Y-31%
FCF growth 3Y3.52%
FCF growth 5Y-4.16%
OCF growth 1Y-17.08%
OCF growth 3Y2.74%
OCF growth 5Y-1.48%